Sanofi moved ahead with a plan to sell a controlling stake in its consumer-healthcare unit Opella to Clayton Dubilier & Rice, ...

The French drugmaker on Monday announced progress on a deal to sell 50% of its subsidiary Opella to Clayton Dubilier & Rice, ...

Earlier this month Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...

Sanofi and CD&R announce a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...

Sanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024 ...

French drama over sovereign paracetamol is really about a deeper ailment: underinvestment.

Plus, James Gorman gets a promotion at Disney and how Jeff Yass turned gambling wins into a colossal trading giant ...

The continent-wide STOXX 600 slipped 0.6%, with the real estate sector leading with a near 2% drop, while energy stocks led ...

The CDC investigates potential bird flu infections in Washington farm workers. Baxter seeks to restore dialysis patient ...

The French drugmaker on Monday announced progress on a deal to sell 50% of its over-the-counter division to Clayton Dubilier ...

By deploying relatable imagery of princesses pooping, Dulcolax has set out to challenge societal norms that teach girls to be ashamed of bodily functions.